The in vivo behavior of copper-64-labeled azamacrocyclic complexes.

[1]  P. Cutler,et al.  Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  Jurriaan Huskens,et al.  Alkaline Earth Metal and Lanthanide(III) Complexes of Ligands Based upon 1,4,7,10-Tetraazacyclododecane-1,7-bis(acetic acid). , 1997, Inorganic chemistry.

[3]  M. Welch,et al.  Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. , 1996, Bioconjugate chemistry.

[4]  M. Welch,et al.  Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  David E Reichert,et al.  Stability and Structure of Activated Macrocycles. Ligands with Biological Applications. , 1996, Inorganic chemistry.

[6]  M. Welch,et al.  In vitro and in vivo evaluation of copper-64-octreotide conjugates. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M J Welch,et al.  RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  P. Fanwick,et al.  Structure-distribution relationships for metal-labeled myocardial imaging agents: comparison of a series of cationic gallium (III) complexes with hexadentate bis(salicylaldimine) ligands. , 1994, Journal of medicinal chemistry.

[9]  K. Zinn,et al.  Production of no‐carrier‐added 64Cu from zinc metal irradiated under boron shielding , 1994, Cancer.

[10]  G. Denardo,et al.  A comparative study of copper‐67 radiolabeling and kinetic stabilities of antibody‐macrocycle chelate conjugates , 1994, Cancer.

[11]  C. J. Mathias,et al.  A gallium-68 radiopharmaceutical that is retained in myocardium: 68Ga[(4,6-MeO2sal)2BAPEN]+. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  M J Welch,et al.  Copper-64-labeled antibodies for PET imaging. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  A. Martell,et al.  Determination and Use of Stability Constants , 1992 .

[14]  A. Martell,et al.  Stabilities of the alkaline earth and divalent transition metal complexes of the tetraazamacrocyclic tetraacetic acid ligands , 1991 .

[15]  T. Kaden,et al.  Antibody labeling with copper-67 using the bifunctional macrocycle 4-[(1,4,8,11-tetraazacyclotetradec-1-yl)methyl]benzoic acid. , 1991, Bioconjugate chemistry.

[16]  A. Sherry,et al.  Stability constants for Gd3+ binding to model DTPA‐conjugates and DTPA‐proteins: Implications for their use as magnetic resonance contrast agents , 1988, Magnetic resonance in medicine.

[17]  S. Denardo,et al.  Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent. , 1985, Analytical biochemistry.

[18]  M. Welch,et al.  Gallium-68 1,1,1-tris (5-methoxysalicylaldiminomethyl) ethane: a potential tracer for evaluation of regional myocardial blood flow. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  K. Wainwright,et al.  Bridging alkylation of saturated polyaza macrocycles: a means for imparting structural rigidity , 1980 .

[20]  M J Welch,et al.  Efficient production of high specific activity 64Cu using a biomedical cyclotron. , 1997, Nuclear medicine and biology.

[21]  G. Denardo,et al.  Comparative serum stability of radiochelates for antibody radiopharmaceuticals. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  G. Denardo,et al.  Serum stability of 67Cu chelates: comparison with 111In and 57Co. , 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.